Thursday, April 18, 2024 4/18/2024

Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.

Award Number: U01FD007503
ORGANIZATION: FOOD AND DRUG ADMINISTRATION
OPDIV: FDA
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

RFA-FD-21-031: PROJECT SUMMARY Collaboration in regulatory systems strengthening and standardization activities to increase access to safe and effective biological products. The overall goal of this continued Cooperative Agreement is to increase access of the global population to safe and effective biological products for the prevention, diagnosis, and treatment of priority diseases, especially for use in LMICs. The project aims to achieve oversight of the current status of regulatory strengthening in priority LMICs; generate the required international framework for global coordination of regulatory systems strengthening; facilitate and ensure scientific collaboration and enhance regulatory capacities of National Regulatory Authorities and networks to advance global access to safe and effective vaccines and other biologicals; support development of science-based and data-driven norms, standards, guidance and approaches to guide national regulatory authorities; and build a strong relationship with the US Food and Drug Administration for collaborative efforts in regulatory systems strengthening and standardization activities in the area of biological products. In line with the Funding Opportunity Announcement, WHO proposes activities under four objectives: 1: Contributing to regulatory systems strengthening in low- and middle-income countries; 2: Enhancing post-market surveillance of vaccines safety; 3: Development of global norms and standards; and 4) Supporting regulatory mission relevant research and other activities to promote development of and increased access to safe and effective biological products. The project will be implemented over 60 months, through 12-months’s phases; managed and implemented by a Project Management Team and technical staff in WHO Headquarters, regional and country offices, with ministries of health, national regulatory authorities, national and professional associations, UN agencies and other relevant partners. WHO draws on a wide network of WHO Collaborating Centres, NGOs and 50 National Professional Officers in ministries of health worldwide. Increasing demand for regulatory systems strengthening, increasingly complex global regulatory environments and more players in the global health arena have prompted WHO to elaborate a new operational model for regulatory systems strengthening with a Coalition of partner organisations and the concepts of regional Centres of Excellence, reliance and WHO Listed Authorities. These new approaches are receiving strong political support from WHO Member States and global health agencies/partnerships.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	WORLD HEALTH ORGANIZATION	AVENUE APPIA 20	GENEVE				CHE	Food and Drug Administration Research	000	3	10/22/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $2,000,000 )
2023	2023	WORLD HEALTH ORGANIZATION	AVENUE APPIA 20	GENEVE				CHE	Food and Drug Administration Research	002	3	9/15/2023	NON-COMPETING CONTINUATION	$0
2023	2023	WORLD HEALTH ORGANIZATION	AVENUE APPIA 20	GENEVE				CHE	Food and Drug Administration Research	001	3	9/5/2023	NON-COMPETING CONTINUATION	$2,000,000
2023	2022	WORLD HEALTH ORGANIZATION	AVENUE APPIA 20	GENEVE				CHE	Food and Drug Administration Research	000	2	11/1/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,000,000

Issue Date FY: 2022 ( Subtotal = $2,000,000 )
2022	2022	WORLD HEALTH ORGANIZATION	AVENUE APPIA 20	GENEVE				CHE	Food and Drug Administration Research	000	2	8/2/2022	NON-COMPETING CONTINUATION	$2,000,000
														Subtotal = $2,000,000

Issue Date FY: 2021 ( Subtotal = $1,200,000 )
2021	2021	WORLD HEALTH ORGANIZATION	AVENUE APPIA 20	GENEVE				CHE	Food and Drug Administration Research	000	1	9/21/2021	NEW	$1,200,000
														Subtotal = $1,200,000

Grand Total All Awards = $5,200,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.

Award Number: U01FD007503

ORGANIZATION: FOOD AND DRUG ADMINISTRATION

OPDIV: FDA

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer